Acute pain physiology and pharmacological targets: The present and future

Acute Pain

Volumn 1, Issue 3, 1998, Pages 31-47

  Serpell, Mick G ^a   Makin, Andy ^a   Harvey, Andrea ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

acute pain; classification; definitions; pain mechanisms; physiological components

Indexed keywords

EID: 0002165364     PISSN: 13660071     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1366-0071(98)80018-1     Document Type: Review

References (97)

1. Merskey H. Pain terms: A list with definitions and notes on usage. Recommended by the IASP Subcommittee on Taxonomy. Pain 6 (1979) 249-252
2. Raj P.P. Characteristics, classification, and assessment of acute postoperative pain. In: Raj P.P. (Ed). Current Review of Pain (1994), Current Medicine, Philadelphia 17-66
3. Woolf C.J. Recent advances in the pathophysiology of acute pain. Br J Anaesth 63 (1989) 139-146
4. McMahon S.B., Dmitrieva N., and Koltzenburg M. Visceral pain. Br J Anaesth 75 (1995) 132-144
5. Devor M. The pathophysiology of damaged peripheral nerves. In: Wall P.D., and Melzack R. (Eds). Textbook of Pain (1994), Churchill-Livingston, London 79-100
6. Fields H.L. Pain (1987), McGraw-Hill, New York 133-169
7. Siddall P.J., and Cousins M.J. Neurobiology of pain. Int Anesthesiol Clin 35 2 (1997) 1-26
8. McMahon S.B., and Koltzenburg M. Novel classes of nociceptors: Beyond Sherrington. Trends Neurosci 13 (1990) 199-201
9. Dray A. Tasting the inflammatory soup: The role of peripheral neurones. Pain Reviews 1 (1994) 153-171
10. Neumann S., Doubell T.P., Leslie T., and Woolf C.J. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurones. Nature 384 6607 (1996) 360-364
11. Dray A. Inflammatory mediators of pain. Br J Anaesth 75 (1995) 125-131
12. 8Bk and HOE 140, in two models of persistent hyperalgesia in the rat. Pain 53 (1993) 191-197
13. Dray A., and Perkins M. Bradykinin and inflammatory pain. Trends Neurosci 16 (1993) 99-104
14. Hla T., and Nielson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89 (1992) 7389-7398
15. Coleman R.A., Smith W.L., and Narumiya S. Classification of prostanoid receptors: Properties, distribution and structure of the receptors and their subtypes. Pharmacological Reviews 46 (1994) 205-229
16. McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 59 (1994) 9-43
17. Liu K., Hsu C.C., and Chia Y.Y. Effect of dexamethasone on postoperative emesis and pain. Br J Anaesth 80 (1998) 85-86
18. Griffiths R.J., Pettipher E.R., Koch K., Farrell C.A., et al. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci USA 92 (1995) 517-521
19. Stein C., Comisel K., Haimerl E., Yassouridis A., et al. Analgesic effects of intra-articular morphine after arthroscopic knee surgery. N Engl J Med 325 (1991) 1123-1126
20. Stein C. Peripheral mechanisms of opioid analgesia. Anesth Analg A76 (1993) 182-191
21. Rumore M.M., and Schlichting D.A. Analgesic effects of antihistamines. Life Sci 36 (1985) 403-406
22. Levine J.D., Fields H.L., and Basbaum A.I. Peptides and the primary afferent nociceptor. J Neurosci 13 (1993) 23-93
23. Humphrey P., and Fenuik W. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci 12 (1991) 444-446
24. Sawynok J., and Sweeney M.I. The role of purines in nociception. Neuroscience 32 (1989) 557-569
25. Sawynok J., Sweeney M.I., and White T.D. Adenosine release may mediate spinal analgesia by morphine. Trends Pharmacol Sci 10 (1989) 186-189
26. Karlston R., Gordh T., and Post C. Local antinociceptive and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogues in mice. Pharmacol Toxicol 71 (1992) 60-64
27. Keil G.J., and DeLander G.E. Spinally-mediated antinociception is induced in mice by adenosine kinase-, but not by an adenosine deaminase-, inhibitor. Life Sci 51 (1992) PL171-PL176
28. Steen K.H., Steen A.E., Kreysel H.W., and Reeh P.W. Inflammatory mediators potentiate pain induced by experimental tissue acidosis. Pain 66 2-3 (1996) 163-170
29. Winter J., Bevan S., and Campbell E.A. Capsaicin and pain mechanisms. Br J Anaesth 75 (1995) 157-168
30. Davis A.J., and Perkins M.N. The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia. Br J Pharmacol 113 (1994) 63-68
31. Jonakait G.M. Neural-immune interactions in sympathetic ganglia. Trends Neurosci 10 (1993) 419-423
32. Cunha F.Q., Poole S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. Br J Pharmacol 107 (1992) 660-664
33. Lee J.C., Badger A.M., Griswold D.E., Dunnington D., et al. Bicyclic imidazolines as a novel class of cytokine biosynthesis inhibitors. Ann NY Acad Sci 696 (1993) 149-170
34. Woolf C.J., Safieh-Garabedian B., Ma Q.-P., Crilly P., et al. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 62 (1994) 327-331
35. Kinnman E., Nygardis E.B., and Hansson P. Peripheral adenoreceptors are involved in the development of capsaicin induced ongoing and stimulus evoked pain in humans. Pain 69 (1997) 79-85
36. Raja S.N. Role of the sympathetic nervous system in acute pain and inflammation. Ann Med 27 (1995) 241-246
37. Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull 47 (1991) 644-666
38. Rang H.P., Bevan S.J., and Dray A. Nociceptive peripheral neurons: Cellular properties. In: Wall P.D., and Melzack R. (Eds). Textbook of Pain (1994), Churchill-Livingston, London 57-78
39. Edwards G., and Weston A.H. The pharmacology of ATP-sensitive potassium channels. Ann Rev Pharmacol Toxicol (1993) 597-637
40. (abstract). Xiao W.-H., and Bennett G.J. Inhibition of neuropathic pain by N-type calcium channel blockade with omega-conopeptides applied to the site of nerve injury. Society for Neuroscience 20 (1994) 559
41. Melzack R., and Wall P.D. Pain mechanisms: A new theory. Science 150 (1965) 971-979
42. Price D.D., Mao J., and Mayer D.J. Neural mechanisms of normal and abnormal pain states. In: Raj P.P. (Ed). Current Review of Pain (1994), Current Medicine, Philadelphia 1-16
43. Mendell L.M. Physiological properties of unmyelinated fibre projections to the spinal cord. Exp Neurology 16 (1966) 316-332
44. Cook A.J., Woolf C.J., Wall P.D., and McMahon S.B. Dynamic receptive field plasticity in the rat spinal cord dorsal horn following C-primary afferent input. Nature 325 (1987) 151-153
45. Dickenson A.H., and Sullivan A.F. Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain 30 (1987) 349-360
46. McQuay H.J. Pre-emptive analgesia (Editorial). Br J Anaesth 69 (1992) 1-3
47. Dahl J.B., and Kehlet H. The value of pre-emptive analgesia in the treatment of postoperative pain. Br J Anaesth 70 (1993) 434-439
48. Bach S., Noreng M.F., and Tjéllden N.U. Phantom limb pain in amputees during the first 12 months following limb amputation, after preoperative lumber epidural blockade. Pain 33 (1988) 297-301
49. Katz J., Jackson M., Kavanagh B.P., and Sandler A.N. Acute pain after thoracic surgery predicts long-term post thoracotomy pain. Clin J Pain 12 (1996) 50-55
50. Coderre T.J., Katz J., Vaccarino A.L., and Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52 (1993) 259-285
51. Akopian A.N., Abson N.C., and Wood J.N. Molecular genetic approaches to nociceptor development and function. Trends Neurosci 19 (1996) 240-246
52. Besse D., Lombard M.C., Zakac J.M., Roques B.P., et al. Pre- and post-synaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res 521 (1990) 15-22
53. Morgan M. The rational use of intrathecal and extradural opioids. Br J Anaesth 63 (1989) 165-188
54. Hori Y., Endo K., and Takahashi T. Presynaptic inhibitory action of enkephalin on excitatory transmission in superficial dorsal horn of rat spinal cord. J Physiol 450 (1992) 673-685
55. Dickenson A.H., Sullivan A.F., Fournie-Zaluski M.C., Costentin J., and Roques B.P. Prevention of degradation of endogenous enkephalins produces inhibition of nociceptive neurones in rat spinal cord. Brain Res 408 (1987) 185-191
56. Xu X.-J., Puke M.J.C., Verge V.M., Wiesenfeld-Hallinz, et al. Up-regulation of cholecystokinnin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat. Neurosci Letts 152 (1993) 129-132
57. 2-adrenoreceptor agonists in rats. Anesthesiology 81 (1994) 677-688
58. Advokat C., and Rhein F.Q. Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan. Brain Res 699 (1995) 157-160
59. Davis K.D., Treede R.D., Raja S.N., Meyer R.A., et al. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 47 (1991) 309-317
60. Eisenach J.C. Physiology and pharmacology of blockade: alpha 2 and other agonists. Congress Manual of International Society of Regional Anaesthesia. Auckland (1996) 30-34
61. Eisenach J.C., DuPen S., Dubois M., Migue I.R., et al. Epidural clonidine for intractable cancer pain. Pain 61 (1995) 391-399
62. Kamibayashi T., and Maze M. Perioperative use of alpha-2 adrenergic agonists. Current Opinion in Anaesthesiology 9 (1996) 323-327
63. Dickenson A.H. Spinal cord pharmacology of pain. Br J Anaesth 75 (1995) 193-200
64. Birch P.J., Grossman C.J., and Hayes A.G. Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol 154 (1988) 85-87
65. Backonja M., Arndt G., Gombar K.A., Check B., et al. Response of chronic neuropathic pain syndromes to ketamine: A preliminary study. Pain 56 (1994) 51-57
66. Edwards M., Serrao J.M., Gent, and Goodchild C.S. On the mechanism by which midazolam causes spinally mediated analgesia. Anesthesiology 73 (1990) 273-277
67. Rosland J.H., and Hole K. 1,4-Benzodiazepines antagonize opiate-induced antinociception in mice. Anesth Analg 71 (1990) 242-248
68. Nishiyama T. The post-operative analgesic action of midazolam following epidural administration. Eur J Anaesthesiol 12 (1995) 369-374
69. McCarson K.E., and Krause J.E. NK-1 and NK-3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant of formalin-induced nociception. J Neurosci 14 (1994) 712-720
70. Yamamoto T., and Yaksh T.L. Stereospecific effects of a non-peptidic NK1 selective antagonist, CP-96,345: antinociception in the abscence of motor dysfunction. Life Sci 49 (1991) 1955-1963
71. 516P. Gardener C.J., Bountra C., Bunce K.T., Dale T.J., et al. Anti-emetic activity of neurokinin NK1 receptor antagonists is mediated centally in the ferret. Br J Pharmacol 112 (1994)
72. Shepheard S.L., Williamson D.J., Hill R.G., and Hargreaves R.J. The non-peptide neurokinin 1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br J Pharmacol 108 (1993) 11-12
73. Radhakrishnan V., and Henry J.L. L-NAME blocks responses to NMDA, Substance P and noxious cutaneous stimuli in cat dorsal horn. Neuroreport 4 (1993) 323-326
74. Nagy I., Maggi C.A., Dray A., Woolf C.J., and Urban L. The role of neurokinin and NMDA receptors in capsaicinsensitive synaptic transmission in the dorsal horn of the rat spinal cord. Neuroscience 52 (1993) 1029-1037
75. Morton C.R., and Hutchison W.D. Release of sensory neuropeptides in the spinal cord: studies with calcitonin gene related peptide and galanin. Neuroscience 31 (1989) 807-815
76. Kuraishi Y., Nanayama T., Ohno H., Minami M., et al. Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene-related peptide. Neurosci Letts 92 (1988) 325-329
77. Barber N.S., Dourish C.T., and Hill D.R. The role of CCK caerulein, and CCK antagonists in nociception. Pain 39 (1989) 307-328
78. Woodruff G.N., and Hughes J. Cholecystokinin antagonists. Ann Rev Pharmacol Toxicol 31 (1991) 469-501
79. Betoin F., Ardid D., Gerbert A., Aumaitre O., et al. Evidence for a long-lasting antinociceptive effect of vapreotide, an analogue of somatostatin, involving an opiodergic mechanism. J Pharmacol Exp Ther 269 (1994) 7-14
80. Penn R.D., Paice J.A., and Kroin J.S. Octreotide: A potent new non-opiate analgesic for intrathecal infusion. Pain 49 (1992) 13-19
81. Bartfai T., Fisone G., and Langel U. Galanin and galanin antagonists: Molecular and biochemical perspectives. Trends Pharmacol Sci 13 (1992) 312-317
82. Gordh Jr. T., Jannsson I., Hartvig P., Gillberg P.G., et al. Interactions between noradrenergic and cholinergic mechanisms involved in spinal nociceptive processing. Acta Anaesth Scand 33 (1989) 39-47
83. Spande T.F., Garraggo H.M., Edwards M.W., Yeh H.C.G., et al. Epibatidine: A novel (chlorpyridyl) azabicycloheptane with potent analgesic activity from an Equadorean poison frog. J Am Chem Soc 114 (1992) 3475-3478
84. Hayes R.L., Mao J., Price D.D., Germano A., et al. Pretreatment with gangliosides reduces abnormal nociceptive responses associated with a rodent peripheral mononeuropathy. Pain 48 (1992) 391-396
85. Berman J. Imaging pain in humans. Br J Anaesth 75 (1995) 209-216
86. Stamford J.A. Descending control of pain. Br J Anaesth 75 (1995) 217-227
87. Craig A.D., Reiman E.M., Evans A., and Bushnell M.C. Functional imaging of an illusion of pain. Nature 384 (1996) 258-260
88. Dickenson A.H. Mechanisms of the analgesic actions of opiates and opioids. Br Med Bull 47 (1991) 690-702
89. Reisine T., and Bell G.I. Molecular biology of opioid receptors. Trends Neurosci 16 (1993) 506-510
90. Zadina J.E., Hackler L., Ge L.J., and Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386 (1997) 499-502
91. Henderson G., and McKnight A.T. The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ. Trends Pharmacol Sci 18 (1997) 293-300
92. Coda B.A., Hill H.F., Schaffer R.L., Luger T.J., et al. Enhancement of morphine analgesia by fenfluramine in subjects receiving tailored opioid infusions. Pain 52 (1993) 85-91
93. Raffa R.B., Friderichs E., Reimann W., Shank R.P., et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 260 (1992) 275-285
94. In: McQuay H.J., and Moore R.A. (Eds). Antidepressants and chronic pain, effective analgesia in neuropathic pain and other syndromes. BMJ 314 (1997) 763-764
95. Rang H.P., and Urban L. New molecules in analgesia. Br J Anaesth 75 (1995) 145-156
96. Rang H.P., Bevan S., and Dray A. Chemical activation of nociceptive peripheral neurones. Br Med Bull 47 (1991) 534-548
97. Dickenson A. Pain Reviews 2 (1995) 1-12